Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia. [electronic resource]
Producer: 20200109Description: 96-104 p. digitalISSN:- 2473-9537
- Animals
- Antineoplastic Agents, Immunological -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Clinical Studies as Topic
- Drug Evaluation, Preclinical
- Drug Resistance, Neoplasm
- Humans
- Inotuzumab Ozogamicin -- pharmacology
- Molecular Targeted Therapy
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- diagnosis
- Prognosis
- Recurrence
- Sialic Acid Binding Ig-like Lectin 2 -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.